Magnetic Resonance Image Guided Radiotherapy (MRIgRT) course

Key information

Next course dates

TBC

Registration opens

TBC

Location

ICR and RMH Sutton, SM2 5PT
See Sutton map at the bottom of our contacts page.

This course is organised by The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London.

Course outline

An opportunity to broaden your understanding of the capabilities and potential of MRI guidance in radiotherapy planning and treatment verification. We invite you to join us to hear from leading practitioners in the field, develop skills and share knowledge with other professionals involved in MRI in radiotherapy.

This two day course aims to improve understanding of MRIgRT, focusing on the knowledge and skills required to support current and future needs in radiotherapy.

The development of MRI in radiotherapy planning involves close communication with radiology and radiotherapy professionals. This course is aimed at all professionals involved in or interested in MRI for radiotherapy, including radiographers, physicists and clinicians.

Course Organisers: Dr Helen McNair, Ms Erica Scurr, Dr Shaista Hafeez, Miss Trina Herbert, and Professor Uwe Oelfke

"Great overall knowledge for all professions interested in MRI - extremely informative."
– Therapeutic Radiographer and course attendee

Course overview

The course will include taught and practical workshops to:

Improve understanding of the basic principles of MRI
Build foundation skills to support the increase in demand for MRI simulation
Develop practical skills
Learn about current clinical pathways and the latest research developments

The practical demonstrations will include:

MR simulation, image acquisition and interpretation, RT set up and safety.
Sequence and parameter manipulation
Adaptive workflow on the MR Linac

Provisional lecture list

The clinical need for MR in radiotherapy
Image contrast, Resolution and Factors affecting signal-to-noise
MR Simulation
MR planning workflow
MR-CT fusion planning
Image fusion and dosimetry
Safety considerations
Regional MR in RT – Pelvis,
Regional MR in RT, Abdomen (liver and pancreas)
Regional MR in RT, Breast
Managing motion (4D)
MR in Brachytherapy
MR Linac QA
Diffusion Weighted Imaging (DWI) principles and applications
Functional imaging

Programme overview

Previous comments from attendees

“I have now significantly more knowledge of potential for MRI in radiotherapy, its benefits and drawbacks.” – Clinical Oncologist

“MRI in radiotherapy planning is a lot more complicated than I thought. Highlighted that we would be crazy to do more MRI without an MRI physicist in the trust.” – Radiotherapy Physicist

“Excellent overview of MRI and how it is and will be used in the future.” – Radiotherapy Physicist

“Collaboration between diagnostic and Therapy radiographers is vital in MR planning.” – Therapeutic Radiographer

Accommodation

Accommodation is available in local hotels, details can be supplied upon request.

Further information

For further details on up to date course content call +44 (0)20 8661 3704 or email Cheryl Taylor.

Latest ICR News

Image: Blood samples. Credit: Ahmad Ardity via Pixabay

Genetic testing for Lynch Syndrome prevents cancers being missed

17/01/25

Genetic testing to identify women with Lynch Syndrome is likely to need to increase dramatically to ensure that carriers are not missed, a new analysis by ICR researchers has found.

See full story

Image of immunofluorescence staining of bladder tumour tissue. Some areas appear lighter green, some dark blue, and others black.

MRI scanning and biopsy could reduce delays in the correct treatment for bladder cancer by more than six weeks

16/01/25

Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research suggests that initial MRI imaging and biopsy could be used to reduce the time patients wait.

See full story

A colour-enhanced image showing a clump of prostate cancer cells

Researchers identify two genes responsible for tumour progression in early-stage prostate cancer

16/01/25

An innovative study has uncovered two genes that promote the formation of prostate tumours.

See full story

Red, yellow and blue microscope image of immunofluorescence staining showing extension of prostatic adenocarcinoma into the bladder wall

New drug hope for prostate cancer patients

10/01/25

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and bile duct cancer, according to research published in the journal Clinical Cancer Research.

See full story